A comparison of mindfulness-based stress reduction and an active control in modulation of neurogenic inflammation

Brain, Behavior, and Immunity

Volumn 27, Issue 1, 2013, Pages 174-184

  Rosenkranz, Melissa A ^a   Davidson, Richard J ^a,b,c   MacCoon, Donal G ^a   Sheridan, John F ^d   Kalin, Ned H ^c   Lutz, Antoine ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Inflammation; Mindfulness; Neurogenic; Stress

Indexed keywords

CAPSAICIN; HYDROCORTISONE;

ADULT; ARTICLE; BEHAVIOR THERAPY; CONTROLLED STUDY; EVOKED RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MENTAL STRESS; MINDFULNESS BASED STRESS REDUCTION; NEUROGENIC INFLAMMATION; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RANDOMIZED CONTROLLED TRIAL; STRESS MANAGEMENT; TREATMENT DURATION; TREATMENT RESPONSE; TRIER SOCIAL STRESS TEST;

ADULT; ANALYSIS OF VARIANCE; BLISTER; CAPSAICIN; FEMALE; HUMANS; HYDROCORTISONE; INTERLEUKIN-8; MALE; MEDITATION; MIDDLE AGED; MIND-BODY THERAPIES; NEUROGENIC INFLAMMATION; SALIVA; SELF REPORT; SENSORY SYSTEM AGENTS; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84870764939     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2012.10.013     Document Type: Article

References (88)

1. Abercrombie H.C., Giese-Davis J., Sephton S., Epel E.S., Turner.-Cobb J.M., Spiegel D. Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology 2004, 29:1082-1092.
2. Adam E.K., Gunnar M.R. Relationship functioning and home and work demands predict individual differences in diurnal cortisol patterns in women. Psychoneuroendocrinology 2001, 26:189-208.
3. Arck P., Paus R. From the brain-skin connection: the neuroendocrine-immune misalliance of stress and itch. Neuroimmunomodulation 2006, 13(5-6):347-356.
4. Arck P.C., Slominski A., Theoharides T.C., Peters E.M.J., Paus R. Neuroimmunology of stress: skin takes center stage. J. Invest. Dermatol. 2006, 126:1697-1704.
5. Banik R.K., Sato J., Giron R., Yajima H., Mizumura K. Interactions of bradykinin and norepinephrine on rat cutaneous nocioceptors in both normal and inflamed conditions in vitro. Neurosci. Res. 2004, 49:421-425.
6. Banik R.K., Sato J., Yajima H., Mizumura K. Differences between the Lewis and Sprague-Dawley rats in chronic inflammation induced norepinephrine sensitivity of cutaneous C-fiber nociceptors. Neurosci. Lett. 2001, 299:21-24.
7. Barnes, P.M., Bloom, B., Nahin, R.L., Complementary and Alternative Medicine Use Among Adults and Children: United States, 2007 (National Health Statistics Reports Number 12, U.S. Department of Health and Human Services Publication No. (PHS) 2009-1250;). http://nccam.nih.gov/news/camstats/2007.
8. Barrino A.M., Voltolini S., Fiaschi D., Pellegrini S., Bignardi D., Minale P., Troise C., Maura E. Chronic urticaria: importance of a medical-psychological approach. Eur. Ann. Allergy Clin. Immunol. 2006, 38:149-152.
9. Bender A.E., Bender D.A. Body surface area. A Dictionary of Food and Nutrition 1995, Oxford University Press, New York.
10. Bishop S.R., Lau M., Shapiro S., Carlson L., Anderson N.D., Carmody J., Segal Z.V., Abbey S., Speca M., Velting D., Devins G. Mindfulness: a proposed operational definition. Clin. Psychol. Sci. Pract. 2004, 11:230-241.
11. Bjerring P., Arendt Nielsen L. A quantitative comparison of the effect of local analgesics on argon laser induced cutaneous pain and on histamine induced wheal, flare and itch. Acta Dermatol. Venereol. 1990, 70:126-131.
12. Black P.H. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav. Immun. 2002, 16(6):622-653.
13. Bockelbrink A., Heinrich J., Schäfer I., Zutavern A., Borte M., Herbarth O., Schaaf B., von Berg A., Schäfer T. LISA Study Group, Atopic eczema in children: another harmful sequel of divorce. Allergy 2006, 61:1397-1402.
14. Bower J.E., Ganz P.A., Dickerson S.S., Petersen L., Aziz N., Fahey J.L. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005, 30:92-100.
15. Brydon L., Walker C., Wawrzyniak A., Whitehead D., Okamura H., Yajima J., Tsuda A., Steptoe A. Synergistic effects of psychological and immune stressors on inflammatory cytokine and sickness responses in humans. Brain Behav. Immun. 2009, 23:217-224.
16. Buske-Kirschbaum A., Ebrecht M., Kern S., Hellhammer D.H. Endocrine stress responses in TH1-mediated chronic inflammatory skin disease (psoriasis vulgaris) - do they parallel stress-induced endocrine changes in TH2-mediated inflammatory dermatoses (atopic dermatitis)?. Psychoneuroendocrinology 2006, 31:439-446.
17. Buske-Kirschbaum A., Geiben A., Höllig H., Morschhäuser E., Hellhammer D. Altered responsiveness of the hypothalamaic-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J. Clin. Endocrinol. Metab. 2002, 87:4241-4245.
18. Buske-Kirschbaum A., Hellhammer D.H. Endocrine and immune responses to stress in chronic inflammatory skin disorders. Ann. N. Y. Acad. Sci. 2003, 992:231-240.
19. Buske-Kirschbaum A., Kern S., Ebrecht M., Hellhammer D. Altered distribution of leukocyte subsets and cytokine production in response to acute psychological stress in patients with Psoriasis vulgaris. Brain Behav. Immun. 2007, 21:92-99.
20. Carlson L.E., Speca M., Patel K.D., Goodey E. Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology 2004, 29:448-474.
21. Carmody J., Baer R.A. Relationships between mindfulness practice and levels of mindfulness, medical and psychological symptoms and well-being in a mindfulness-based stress reduction program. J. Behav. Med. 2008, 31:23-33.
22. Carroll J.E., Low C.A., Prather A.A., Cohen S., Fury J.M., Ross D.C., Marsland A.L. Negative affective responses to a speech task predict changes in interleukin (IL)-6. Brain Behav. Immun. 2011, 25:232-238.
23. Chambers R., Gullone E., Allen N.B. Mindful emotion regulation: An integrative review. Clin. Psychol. Rev. 2009, 29:560-572.
24. Cohen L., Cole S.W., Sood A.K., Prinsloo S., Kirschbaum C., Arevalo J.M., Jennings N.B., Scott S., Vence L., Wei Q., Kentor D., Radvanyi L., Tannir N., Jonasch E., Tamboli P., Pisters L. Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: role of inflammatory signaling. PLOS One 2012, 7. epub ahead of publication.
25. Cua D.J., Tato C.M. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 2010, 10:479-489.
26. Cuesta M.C., Quintero L., Pons H., Suarez-Roca H. Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells. Neurochem. Int. 2002, 40:301-306.
27. Derogatis L.R. SCL-90-R administration, scoring and procedures manual-II 1983, Clinical Psychometric Research, Towson, MD.
28. Dickerson S.S., Gable S.L., Irwin M.R., Aziz N., Kemeny M.E. Social-evaluative threat and proinflammatory cytokine regulation: an experimental laboratory investigation. Clin. Psychol. Sci. Pract. 2009, 20:1237-1244.
29. Dickerson S.S., Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol. Bull. 2004, 130:355-391.
30. Drummond P.D. Noradrenaline increases hyperalgesia to heat in skin treated by capsaicin. Pain 1995, 60:311-315.
31. Gibbs B.F., Wierecky J., Welker P., Henz B.M., Wolff H.H., Grabbe J. Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp. Dermatol. 2001, 10:312-320.
32. Glaser R., Kiecolt-Glaser J.K., Marucha P.T., MacCallum R.C., Laskowski B.F., Malarkey W.B. Stress-related changes in proinflammatory cytokine production in wounds. Arch. Gen. Psychiat. 1999, 56:450-456.
33. Gregg J.A., Callaghan G.M., Hayes S.C., Glenn-Lawson J.L. Improving diabetes self-management through acceptance, mindfulness, and values: a randomized controlled trial. J. Consult. Clin. Psychol. 2007, 75:336-343.
34. Grossman P., Van Dam N.T. Mindfulness by any other name: trials and tribulations of sati in western psychology and science. Contemporary Buddhism 2011, 11:219-239.
35. Grossman P., Tiefenthaler-Gilmer U., Raysz A., Kesper U. Mindfulness training as an intervention for fibromyalgia: evidence of postintervention and 3-year follow-up benefits in weil-being. Psychother. Psychosom. 2007, 76:226-233.
36. Gruenewald T.L., Kemeny M.E., Aziz N., Fahey J.L. Acute threat to the social self: shame, social self-esteem, and cortisol activity. Psychosom. Med. 2004, 66:915-924.
37. Härle P., Straub R.H., Wiest R., Mayer A., Schölmerich J., Atzeni F., Carrabba M., Cutolo M., Sarzi-Puttini P. Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems. Ann. Rheumat. Dis. 2006, 65:51-56.
38. Hart A., Kamm M.A. Review article: mechanisms of initiation and perpetuation of gut inflammation by stress. Ailment Pharmacol Ther. 2002, 16:2017-2028.
39. Helme R.D., McKernan S. Neurogenic flare responses following topical application of capsaicin in humans. Ann. Neurol. 1985, 18:505-509.
40. Izumi H., Karita K. Axon reflex flare evoked by nicotine in human skin. Jpn. J. Physiol. 1992, 42:721-730.
41. Jha A.P., Stanley E.A., Kiyonaga A., Wong L., Gelfand L. Examining the protective effects of mindfulness training on working memory capacity and affective experience. Emotion 2010, 10:54-64.
42. Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen. Hosp. Psychiatry 1982, 4:33-47.
43. Kabat-Zinn J. Full catastrophe living: using the wisdom of your body and mind to face stress, pain and illness 1990, Delacorte Press, New York.
44. Kabat-Zinn J., Wheeler E., Light T., Skillings A., Scharf M.J., Cropley T.G., Hosmer D., Bernhard J.D. Influence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemotherapy (PUVA). Psychosom. Med. 1998, 60:625-632.
45. Kabat-Zinn J. Some reflections on the origens of MBSR, skillful means and the trouble with maps. Contemporary Buddhism 2011, 11:281-306.
46. Keller J., Flores B., Gomez R.G., Solvason H.B., Kenna H., Williams G.H., Schaatzberg A.F. Cortisol circadian rhythm alterations in psychotic major depression. Biol. Psychiatry 2006, 60:275-281.
47. Kemeny M.E., Foltz, Cavanagh J.F., Cullen M., Giese-Davis J., Jennings P., Rosenberg E.L., Gillath O., Shaver P.R., Wallace B.A., Ekman P. Contemplative/emotion training reduces negative emotional behavior and promotes prosocial responses. Emotion 2011, 5:1-13.
48. Kim H.S., Cho D.H., Kim H.J., Lee J.Y., Cho B.K., Park H.J. Immunoreactivity of corticotropin-releasing hormone, adrenocorticotropic hormone and alpha-melanocyte-stimulating hormone in alopecia areata. Exp. Dermatol. 2006, 15:515-522.
49. Kirschbaum C., Pirke K.M., Hellhammer D.H. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28:76-81.
50. Kleyn C.E., Schneider L., Saraceno R., Mantovani C., Richards H.L., Fortune D.G., Cumberbatch M., Dearman R.J., Terenghi G., Kimber I., Griffiths C.E. The effects of acute social stress on epidermal Langerhans' cell frequency and expression of cutaneous neuropeptides. J. Invest. Dermatol. 2008, 128:1273-1279.
51. Kumari M., Shipley M., Stafford M., Kivimaki M. Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II study. J. Clin. Endocrinol. Metab. 2011, 96:1478-1485.
52. Kupper T.S., Fuhlbrigge R.C. Immune surveillance in the skin: mechanisms and clinical consequences. Nat. Rev. Immunol. 2004, 4:211-222.
53. Lin Q., Zou X., Fang L., Willis W.D. Sympathetic modulation of acute cutaneous flare induced by intradermal injection of capsaicin in anesthetized rats. J. Neurophysiol. 2003, 89:853-861.
54. Liu L.Y., Coe C.L., Swenson C.A., Kelly E.A., Kita H., Busse W.W. School examinations enhance airway inflammation to antigen challenge. Am. J. Respir. Crit. Care Med. 2002, 165:1062-1067.
55. Lotz M., Vaughan J.H., Carson D.A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988, 241:1218-1221.
56. Ma S.H., Teasdale J.D. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J. Consult. Clin. Psychol. 2004, 72:31-40.
57. MacCoon D.G., Imel Z.E., Rosenkranz M.A., Sheftel J.G., Weng H.Y., Sullivan J.C., Bonus K.A., Stoney C.M., Salomons T.V., Davidson R.J., Lutz A. The validation of an active control intervention for mindfulness based stress reduction (MBSR). Behav. Res. Ther. 2012, 50:3-12.
58. Matthews K., Schwartz J., Cohen S., Seeman T. Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom. Med. 2006, 68:657-661.
59. McArthur J.C., Stocks A., Hauer P., Cornblath D.R., Griffin J.W. Epidermal nerve fiber density: normative reference range and diagnostic efficiency. Arch. Neurol. 1998, 55:1513-1520.
60. Okayama Y., Ono Y., Nakazawa T., Church M.K., Mori M. Human skin mast cells produce TNF-alpha by substance P. Int. Arch. Allergy Immunol. 1998, 117(Suppl 1):48-51.
61. Pace T.W., Negi L.T., Adame D.D., Cole S.P., Sivilli T.I., Brown T.D., Issa M.J., Raison C.L. Effect of compassion meditation on neuroendocrine, innate immune and behavioral responses to psychosocial stress. Psychoneuroendocrinology 2009, 34:87-98.
62. Park S.H., Hsiao G.Y., Hwang G.T. Role of substance P and calcitonin gene-related peptide in the regulation of interleukin-8 and monocyte chemotactic protein-1 expression in human dental pulp. Int. Endod. J. 2004, 37:185-192.
63. Pavlovic S., Daniltchenko M., Tobin D.J., Hagen E., Hunt S.P., Klapp B.F., Arck P.C., Peters E.M. Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J. Invest. Dermatol. 2008, 128:434-446.
64. Peters E., Handjiski B., Kuhlmei A., Hagen E., Bielas H., Braun A., Klapp B.F., Paus R., Arck P.C. Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. Am. J. Pathol. 2004, 165:259-271.
65. Peters E., Ericson M.E., Hosoi J., Seiffert K., Hordinsky M.K., Ansel J.C., Paus R., Scholzen T.E. Neuropeptide control mechanisms in cutaneous biology: physiological and clinical significance. J. Invest. Dermatol. 2006, 126:1937-1947.
66. Petersen L.J., Church M.K., Skov P.S. Histamine is released in the wheal but not the flare following challenge of human skin in vivo: a microdialysis study. Clin. Exp. Allergy 1997, 27:284-295.
67. Pradhan E.K., Baumgarten M., Langenberg P., Handwerger B., Gilpin A.K., Magyari T., Hochberg M.C., Berman B.M. Effect of mindfulness-based stress reduction in rheumatoid arthritis patients. Arthritis Rheumat. 2007, 57:1134-1142.
68. Pruessner J., Kirschbaum C., Meinlschmid G., Hellhammer D. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003, 28:916-931.
69. Rohleder N., Wolf J.M., Herpfer I., Fiebich B.L., Kirschbaum C., Lieb K. No response of plasma substance P, but delayed increase of interleukin-1 receptor antagonist to acute psychosocial stress. Life Sci. 2006, 78:3082-3089.
70. Rosenkranz M.A. Substance P at the nexus of mind and body in chronic inflammation and affective disorders. Psychol. Bull. 2007, 133:1007-1037.
71. Saint-Mezard P., Chavagnac C., Bosset S., Ionescu M., Peyron E., Kaiserlian D., Nicolas J.F., Bérard F. Psychologial stress exerts an adjuvant effect of skin dendritic cell functions in vivo. J. Immunol. 2003, 171:4073-4080.
72. Sato J., Suzuki S., Iseki T., Kumazawa T. Adrenergic excitation of cutaneous nocioceptors in chronically inflamed rats. Neurosci. Lett. 1993, 164:225-228.
73. Schmelz M., Luz O., Averbeck B., Bickel A. Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis. Neurosci. Lett. 1997, 230:117-120.
74. Scholzen T., Armstrong C.A., Bunnett N.W., Luger T.A., Olerud J.E., Ansel J.C. Neuropeptides in the skin: interactions between the neuroendocrine and skin immune systems. Exp. Dermatol. 1998, 7:81-96.
75. Schommer N.C., Hellhammer D.H., Kirschbaum C. Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal-medullary system to repeated psychosocial stress. Psychosom. Med. 2003, 65:450-460.
76. Sephton S.E., Sapolsky R.M., Kraemer H.C., Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J. Natl. Cancer Inst. 2000, 92:994-1000.
77. Serra M.C., Calzetti F., Ceska M., Cassatella M.A. Effect of substance P on superoxide anion and IL-8 production by human PMNL. Immunology 1994, 82:63-69.
78. Speca M., Carlson L.E., Goodey E., Angen M. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom. Med. 2000, 62:613-622.
79. Spiegel D., Giese-Davis J., Taylor C.B., Kraemer H. Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis function. Psychoneuroendocrinology 2006, 31:1231-1244.
80. Stawski R.S., Almeida D.M., Lachman M.E., Tun P.A., Rosnick C.B., Seeman T. Associations between cognitive function and naturally occurring daily cortisol during middle adulthood: timing is everything. J. Gerontol. B. Psychol. Sci. Soc. Sci. 2011, 66(Suppl 1):i71-i81.
81. Steptoe A., Hamer M., Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav. Immun. 2007, 21:901-912.
82. Straub R.H., Herfarth H., Falk W., Andus T., Schölmerich J. Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease?. J. Neuroimmunol. 2002, 126:116-125.
83. Anxiety. The instruments of Psychiatric Research 1989, 127-155. Wiley, New York. C. Thompson (Ed.).
84. Travis J.W. Wellness Workbook for Health Professionals 1977, Wellness Resource Center, Mill Valley, CA.
85. Urry H., van Reekum C.M., Johnstone T., Kalin N.H., Thurow M.E., Schaefer H.S., Jackson C.A., Frye C.J., Greischar L.L., Alexander A.L., Davidson R.J. Amygdala and ventromedial prefrontal cortex are inversely coupled during regulation of negative affect and predict the diurnal pattern of cortisol secretion among older adults. J. Neurosci. 2006, 26:4415-4425.
86. Uter W., Hegewald J., Kränke B., Schnuch A., Gefeller O., Pfahlberg A. The impact of meteorological conditions on patch test results with 12 standard series allergens (fragrances, biocides, topical ingredients). Br. J. Dermatol. 2008, 158:734-739.
87. Welk U., Herforth A., Kolb-Bachofen V., Deinzer R. Acute stress induces proinflammatory signaling at chronic inflammation sites. Psychocom. Med. 2008, 70:906-912.
88. Wright R.J., Cohen R.T., Cohen S. The impact of stress on the development and expression of atopy. Curr. Opin. Allergy Clin. Immunol. 2005, 5:23-29.